Image source: The Motley Fool.
Paratek Pharmaceuticals (NASDAQ: PRTK)
Q2 2022 Earnings Call
Aug 03, 2022 , 4:30 p.m. ET
Operator
For further details see:
Paratek Pharmaceuticals (PRTK) Q2 2022 Earnings Call TranscriptImage source: The Motley Fool.
Paratek Pharmaceuticals (NASDAQ: PRTK)
Q2 2022 Earnings Call
Aug 03, 2022 , 4:30 p.m. ET
Operator
For further details see:
Paratek Pharmaceuticals (PRTK) Q2 2022 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Paratek Pharmaceuticals Inc. Company Name:
PRTK Stock Symbol:
Market:
Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...
Paratek Pharmaceuticals Inc. (PRTK) is expected to report $-0.25 for Q3 2023
BOSTON, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and military ...